AuraVax Therapeutics
AuraVax Therapeutics, Inc. (AuraVax) is a privately held biotechnology companycommercializing a new STING activation platform “NanoSTING” as an intranasal hostdirected-therapeutic for the treatment and prevention of upper respiratoryinfections (URI) independent of the infecting pathogen(s).
Cryptyx Bioscience
The Cryptyx Bioscience drug discovery platform provides a rapid, efficient approach for activating silent biosynthetic gene clusters and unearthing potential leads that cannot be accessed with extant technologies.
Nitro Bioscience
Nitro Biosciences is developing a next-generation antigen engineering platform to address issues of immune imprinting in vaccine development. The company is focused on applying its platform toward development of a lead candidate for a universal influenza vaccine.
Sona Global
Sona Global is a group of surgeons, traumatologists, engineers, global health specialists, students, and innovators who believe that safe and high-quality trauma and orthopaedic surgery should be available to all people worldwide, regardless of country or context. They supply innovative devices that help surgeons provide essential trauma care to the poor and vulnerable. Their negative […]
